NETRIS Pharma Welcomes Eric Falcand as Independent Director to Its Board of Directors
3ème édition du CHU HealthTech Connexion Day : L’innovation à l’hôpital au cœur des enjeux de la santé de demain
NETRIS Pharma Receives Best Biotech Pitch Award at EIC and Johnson & Johnson Healthcare Investor Day (powered by Bpifrance – Euroquity)
NETRIS Pharma Announces FDA Orphan Drug Designation (ODD) for NP137 in Pancreatic Cancer Treatment